The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinicopathological characteristics of exceptional responders who achieve durable remissions beyond five years (DR5) in HER2+(H+) metastatic breast cancer (MBC).
 
Darko Skrobo
No Relationships to Disclose
 
Naomi Walsh
No Relationships to Disclose
 
Jose Berenguer
No Relationships to Disclose
 
Janice Maria Walshe
Honoraria - Pfizer; Roche
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Roche; Roche/Genentech
 
Michaela Jane Higgins
Travel, Accommodations, Expenses - Roche
 
David William Fennelly
No Relationships to Disclose
 
Jo Ballot
No Relationships to Disclose
 
Cecily Quinn
Speakers' Bureau - Exact Sciences; Roche
 
Giuseppe Gullo
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
John Crown
Employment - OncoMark
Stock and Other Ownership Interests - OncoMark
Honoraria - MSD Oncology; Novartis Ireland Ltd.; Pfizer; Roche
Consulting or Advisory Role - G1 Therapeutics; MSD Oncology; Novartis Ireland Ltd.; Pfizer; Puma Biotechnology; Roche
Speakers' Bureau - Pfizer
Research Funding - Boehringer Ingelheim (Inst); Eisai (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - WO2020011770 (A1) - A method of predicting response to treatment in cancer patients
Travel, Accommodations, Expenses - Abbvie; Daiichi Sankyo Europe GmbH; MSD; Novartis Ireland Ltd.; Pfizer; Roche